Effect of BET Protein Inhibition With Apabetalone on Cardiovascular Outcomes in Patients With Acute Coronary Syndrome and Diabetes

Effect of BET Protein Inhibition With Apabetalone on Cardiovascular Outcomes in Patients With Acute Coronary Syndrome and Diabetes - Results of the BETonMACE Trial

Ray, KK; Nicholls, SJ; Ginsberg, HN; Johansson, JO; Kalantar-Zadeh, K; Kulikowski, E; Toth, PP; Wong, N; Sweeney, M; Schwartz, GG

CIRCULATION, 2019; 140 (25): E966